About
Rochelle D’Souza obtained a PhD in 2014 wherein she employed MS-based proteomics to study mammalian cell biology at the Max Plank Institute of Biochemistry in Munich, Germany. In 2016 after she joined QIMR Berghofer, she was awarded a PdCCRS grant from Cancer Australia to understand the role of the Eph-ephrin system in GBM. Rochelle currently works on validating the role of ephrin A5 in glioblastoma and combining it with EphA3 to perform dual targeting of both; to tackle the challenge of tumour heterogeneity. She has employed her skills to support several projects in the laboratory. Over her career Rochelle has published 17 research papers with >1,500 citations, has/is mentoring several PhD/master’s students and is co-supervising 1 PhD student.